Exposing “Bright” Metals: Promising Advances in Photoactivated Anticancer Transition Metal Complexes

Title:Exposing “Bright” Metals: Promising Advances in Photoactivated Anticancer Transition Metal Complexes

Volume: 25 Issue: 4

Author(s): Aleksandra Bjelosevic, Benjamin J. Pages, Lawson K. Spare, Krishant M. Deo, Dale L. Ang and Janice R. Aldrich-Wright*

Affiliation:

• Nanoscale Organisation and Dynamics Group, School of Science and Health, Western Sydney University, Penrith, NSW 2751,Australia

Keywords: Photodynamic therapy, transition metals, cancer, irradiation, light, reactive oxygen species.

Abstract: Background: Photodynamic therapy (PDT) is an increasingly prominent field in anticancer research. PDT agents are typically nontoxic in the absence of light and can be stimulated with nonionising irradiation to “activate” their cytotoxic effect. Photosensitzers are not classified as chemotherapy drugs although it is advantageous to control the toxicity of a drug through localised irradiation allowing for selective treatment. Transition metals are an extremely versatile class of compounds with various unique properties such as oxidation state, coordination number, redox potential and molecular geometry that can be tailored for specific uses. This makes them excellent PDT candidates as their properties can be manipulated to absorb a specific range of light wavelengths, cross cellular membranes or target specific sites in vitro. This article reviews recent advances in transition metal PDT agents, with a focus on structural scaffolds from which several metal complexes in a series are synthesised, as well as their in vitro cytotoxicity in the presence or absence of irradiation.

Conclusion: The success of clinical photoactive agents such as Photofrin® has inspired the development of thousands of potential PDT agents. Transition metal complexes in particular have demonstrated excellent versatility and diversity when it comes to PDT for treatment of invasive cancers. This review has highlighted some of the many recent advances of transition metal PDT agents with high in vitro and in vivo phototoxic activity. Photoactive transition metal complexes have proven their potential due to their inherent physicochemical variety, allowing them to fill a niche in the PDT world.

Cite this article as:

Bjelosevic Aleksandra, Pages J. Benjamin , Spare K. Lawson , Deo M. Krishant, Ang L. Dale and Aldrich-Wright R. Janice *, Exposing “Bright” Metals: Promising Advances in Photoactivated Anticancer Transition Metal Complexes, Current Medicinal Chemistry 2018; 25 (4) . https://dx.doi.org/10.2174/0929867324666170530085123